BioSpace News Archive

Cardax, Inc. announced the filing of a Form 15 with the U.S. Securities and Exchange Commission to voluntarily suspend its reporting obligations under Section 15 of the Securities Exchange Act of 1934.

DiaMedica Therapeutics Inc. today provided a business update and financial results for the quarter ended June 30, 2021. DiaMedica will host a conference call Thursday, August 12, 2021, at 7:00AM Central Time/8:00AM Eastern Time to discuss its business update and second quarter financial results.

Surrozen, Inc., a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, announced the completion of its business combination with Consonance-HFW Acquisition Corp., a special purpose acquisition company sponsored by entities affiliated with Consonance Capital Management.

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the Company will release its 2021 second quarter financial results on Monday, August 16, 2021, after the close of the U.S. financial markets.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the U.S. Food and Drug Administration (FDA) has approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).

Cali Biosciences Co., Ltd. (hereinafter referred to as “CaliBio”), a global biopharmaceutical company focused on the research and development of innovative drugs, announced it has initiated a Phase 2b study of its perioperative long-acting analgesic product CPL- 01.

The global fertility services industry garnered $20.38 billion in 2019, and is expected to generate $25.70 billion by 2027, witnessing a CAGR of 15.9% from 2020 to 2027.

Increase in prevalence of seasonal influenza and R&D of new influenza vaccines play a major role in the growth of the influenza vaccine market.

Genmab Announces Financial Results for the First Half of 2021

Milestone Scientific Inc. today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, August 16, 2021 to discuss the Company’s financial results for the second quarter ended June 30, 2021, as well as the Company’s corporate progress and other developments.